| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.7B | $12.6B | $11.8B | $12.0B | $9.7B | $8.4B | $2.3B | $2.3B |
| Cost of Revenue | — | — | — | — | — | — | — | $3.0B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.5B | $1.5B | $1.4B | $1.4B | $1.1B | $0.9B | $0.9B | $0.9B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.5B | $0.5B | $0.4B | $0.9B | $0.5B | $-0.1B | $-0.1B | $0.1B |
| EPS (Basic) | $12.15 | $11.29 | $8.89 | $17.41 | $9.87 | $-2.34 | $-1.02 | $2.07 |
| EPS (Diluted) | $11.94 | $11.06 | $8.73 | $17.04 | $9.66 | $-2.34 | $-1.02 | $2.06 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.4B | $16.7B | $15.8B | $14.4B | $13.8B | $12.9B | $14.5B | $13.1B |
| Current Assets | $2.5B | $2.5B | $2.3B | $2.2B | $2.5B | $1.6B | $1.6B | $1.6B |
| Cash & Equivalents | $0.2B | $0.2B | $0.2B | $0.3B | $0.2B | $0.2B | $0.1B | $0.1B |
| Total Liabilities | $13.3B | $13.6B | $12.7B | $11.5B | $11.0B | $10.7B | $12.0B | $10.1B |
| Current Liabilities | $2.8B | $3.3B | $3.6B | $3.3B | $3.2B | $2.1B | $2.6B | $2.3B |
| Stockholders' Equity | $3.1B | $3.1B | $3.1B | $2.9B | $2.8B | $2.3B | $2.5B | $2.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.6B | $2.3B | $2.4B | $2.3B | $2.2B | $2.2B | $2.1B | — |
| Investing Cash Flow | $-1.6B | $-2.4B | $-2.7B | $-1.9B | $-1.4B | $-0.6B | $-3.2B | — |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.9B | $0.2B | $0.3B | $-0.9B | $-0.2B | $-1.5B | $1.1B | — |